.85. ANTH has traded 15.2 million shares so far today, way above its average volume of 538 thousand shares." />

Nasdaq Losers This Afternoon: ANTH, SNTA, GEVO, VRTX, ARNA, SUPN

NasdaqAnthera Pharmaceuticals, Inc. (NASDAQ:ANTH) is down 69.17% today at $0.85. ANTH has traded 15.2 million shares so far today, way above its average volume of 538 thousand shares. ANTH shares are plummeting today after Lupus drug fails to meet endpoints. The company has a market cap of 34.72 million. Sign Up For Free Stock Alerts

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is down 33.79% today at $4.80. SNTA has traded 3.05 million shares so far today, well above its daily average of 594 thousand shares. SNTA shares are falling today after the company announced results of lung cancer study. The company has a market cap of 281.16 million.

Gevo, Inc. (NASDAQ:GEVO) is down 19.41% today at $5.48. GEVO has traded 754 thousand shares today, more than 3 times its normal volume. GEVO shares have fallen from $9 to $5.50 this week after announcing public offering. The company has a market cap of 143.74 million.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is down 15.20% today at $51.78. VRTX has traded 11.6 million shares today, above its daily average of 3.8 million shares. VRTX shares are falling today after reporting phase 2 data from a study testing its new cystic fibrosis drug. The company has a market cap of 11.09 billion.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is down 11.27% today at $10.10. ARNA has traded 40.6 million shares so far today, nearly double its average of 21 million shares. ARNA shares are down today as traders lock in gains from its massive run up earlier this year from $2. The company has a market cap of 1.86 billion. Sign Up For Free Stock Alerts

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) is down 12.28% today at $10.07. SUPN has traded 374 thousand shares so far today, above its average of 186 thousand shares. SUPN shares are down for the second straight day after the stock jumped from $6 to $14 earlier this week on FDA update news. The company has a market cap of 246.26 million.

Enjoy this post? Please share...
About Kyle Pinder

Kyle Pinder has has over five years trading and research experience in the large cap space. While still in grad school, Kyle trades daily and keep Active Investor up to date with the latest breaking news coming out of Wall Street and Washington.

Speak Your Mind

*

Real Time Web Analytics